All > New Mexico > Albuquerque

Clobetasol Group for Vulvar Lichen Sclerosus

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Vulvar Lichen SclerosusClobetasol Propionate 0.05% Ointment - Drug
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial is designed to see if the traditional therapy of clobetasol combined with FxCO2-laser therapy is more effective than just FxCO2-laser therapy alone in women with vulvar lichen sclerosus.

Eligible Conditions
  • Vulvar Lichen Sclerosus

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Similar Trials

1
Ixekizumab Auto-Injector
1
Topical steroid
1
Ruxolitinib cream

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: About 5 months (baseline to final visit)

Month 5
Treatment response - genital self image
Urination
Treatment response - sexual function
Treatment response - vulvovaginal symptoms
Treatment success
Week 6
Participant-perceived improvement
Participant-perceived treatment satisfaction

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
Ixekizumab Auto-Injector
2
Topical steroid
2
Ruxolitinib cream

Trial Design

2 Treatment Groups

Clobetasol Group
1 of 2
Placebo Group
1 of 2

Active Control

Non-Treatment Group

184 Total Participants · 2 Treatment Groups

Primary Treatment: Clobetasol Group · Has Placebo Group · Phase 4

Clobetasol GroupActiveComparator Group · 2 Interventions: Clobetasol Propionate 0.05% Ointment, Fractionated CO2-laser · Intervention Types: Drug, Device
Placebo Group
Device
PlaceboComparator Group · 1 Intervention: Fractionated CO2-laser · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: about 5 months (baseline to final visit)

Who is running the clinical trial?

Society of Gynecologic SurgeonsUNKNOWN
Patty Brisben Foundation For Women's Sexual HealthOTHER
6 Previous Clinical Trials
211 Total Patients Enrolled
Medstar Health Research InstituteLead Sponsor
175 Previous Clinical Trials
133,892 Total Patients Enrolled
1 Trials studying Vulvar Lichen Sclerosus
52 Patients Enrolled for Vulvar Lichen Sclerosus

Eligibility Criteria

Age 18+ · Female Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are willing and able to undergo concomitant 0.05% clobetasol propionate treatment.

Who else is applying?

What state do they live in?
Texas25.0%
Michigan25.0%
Pennsylvania25.0%
Other25.0%
How old are they?
18 - 65100.0%
What site did they apply to?
The University of New Mexico100.0%
What portion of applicants met pre-screening criteria?
Met criteria50.0%
Did not meet criteria50.0%
What questions have other patients asked about this trial?
  • "How long is the trial and out of pocket cost for me?"
How many prior treatments have patients received?
2100.0%
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top